Facilitated By

San Antonio Medical Foundation

News

  • OMG, omicron: Why I'm not panicking about the new variant - San Antonio Report

    Following the opening of booster vaccinations, University Health pharmacy technicians pre-dose syringes of the Pfizer vaccine against COVID-19 ...

  • Black women at greatest risk for breast cancer-related lymphedema - Healio

    ... to study results presented at San Antonio Breast Cancer Symposium. ... Immunomedics, Novartis, Pfizer, Puma Biotechnology and Seagen.

  • HiberCell To Present New Data on Odetiglucan Plus Pembrolizumab in Ongoing Phase 2 ...

    07, 2021 (GLOBE NEWSWIRE) -- HiberCell, a clinical-stage biotechnology company developing therapeutics to address therapeutic resistance, ...

  • The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More ... - Benzinga

    2021 San Antonio Breast Cancer Symposium Presentations. Gilead Sciences, Inc. (NASDAQ: GILD): Phase 3 data from the ASCENT study of Sacituzumab ...

  • Boston Properties, Alexandria lease San Francisco building to biotech - The Business Journals

    ... are leasing a building under construction — the first phase of a life sciences campus in South San Francisco — to biotech giant Genentech Inc.